US Stock MarketDetailed Quotes
MREO Mereo BioPharma
- 4.8300
- +0.3200+7.10%
Close Aug 23 16:00 ET
- 4.9000
- +0.0700+1.45%
Post 18:58 ET
743.11MMarket Cap-19320P/E (TTM)
5.0200High4.6000Low1.90MVolume4.6200Open4.5100Pre Close9.19MTurnover1.95%Turnover RatioLossP/E (Static)153.85MShares5.020052wk High9.45P/B469.58MFloat Cap1.070052wk Low--Dividend TTM97.22MShs Float8.4800Historical High--Div YieldTTM9.31%Amplitude0.3010Historical Low4.8470Avg Price1Lot Size
Mereo BioPharma Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 10M | 9M | 0 | 0 | 49.21M | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --10M | --9M | --0 | --0 | --49.21M | --0 | --0 | --0 |
| Cost of revenue | 0 | 0 | 324.61%2.57M | 3.43M | -347K | -104.74%-1.15M | 24.17M | 0 | 0 | -34.40%22.7M |
| Gross profit | 0 | 0 | 547.99%7.43M | 5.57M | 347K | -95.42%1.15M | 25.04M | 0 | 0 | 34.40%-22.7M |
| Operating expense | 116.06%12.45M | -16.30%9.42M | -35.81%34.56M | 5.76M | 11.26M | 1.02%53.84M | 4.10%53.3M | -1.18%51.2M | 340.03%51.81M | 10.08%11.78M |
| Selling and administrative expenses | 194.79%7.87M | -8.43%5.91M | -29.43%18.42M | --2.67M | --6.45M | 21.41%26.11M | -25.65%21.5M | 38.65%28.92M | 77.15%20.86M | 10.08%11.78M |
| -General and administrative expense | 194.79%7.87M | -8.43%5.91M | -29.43%18.42M | --2.67M | --6.45M | 21.41%26.11M | -25.65%21.5M | 38.65%28.92M | 77.15%20.86M | 10.08%11.78M |
| Research and development costs | 33.24%4.95M | -24.74%3.99M | -40.89%17.42M | --3.71M | --5.31M | -7.33%29.47M | 42.72%31.8M | -28.03%22.28M | --30.95M | ---- |
| Other operating expenses | 40.58%-369K | 4.41%-477K | 25.93%-1.28M | ---621K | ---499K | ---1.73M | ---- | ---- | ---- | ---- |
| Operating profit | -6,450.00%-12.45M | 13.64%-9.42M | 48.51%-27.14M | -190K | -10.91M | -86.50%-52.7M | 44.81%-28.26M | 1.18%-51.2M | -50.28%-51.81M | 23.90%-34.48M |
| Net non-operating interest income expense | 134.76%228K | 162.15%307K | 77.51%-750K | -656K | -494K | 38.55%-3.34M | 37.18%-5.43M | -48.06%-8.64M | -112.32%-5.83M | -3,715.79%-2.75M |
| Non-operating interest income | 49.87%559K | 101.63%617K | 153.69%2.13M | --373K | --306K | 62,138.96%840K | -80.19%1.35K | -97.16%6.81K | -21.84%239.94K | -62.88%307K |
| Non-operating interest expense | -67.83%331K | -61.25%310K | -30.99%2.88M | --1.03M | --800K | -22.68%4.18M | -37.92%5.4M | 37.73%8.7M | 106.74%6.32M | 514.69%3.06M |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | ---- | 153.33%28.34K | 77.97%-53.15K | ---241.25K | ---- |
| Other net income (expense) | 95.80%-38K | 124.59%165K | -116.13%-2.11M | -905K | -671K | -75.25%13.1M | 131.68%52.9M | -4,570.69%-167M | 4,769.39%3.74M | 95.36%-80K |
| Gain on sale of security | 95.80%-38K | 124.81%165K | -117.50%-2.1M | ---905K | ---665K | -77.23%12.01M | 134.66%52.75M | -8,647.11%-152.19M | 173.93%1.78M | 137.72%650K |
| Special income (charges) | ---- | ---- | ---- | ---- | ---- | ---- | 101.03%152.51K | -857.90%-14.82M | 367.80%1.95M | ---730K |
| -Less：Restructuring and merger&acquisition | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.36M | --0 |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -181.90%-597.89K | --730K |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | ---- | ---- | ---- | 101.03%152.51K | ---14.82M | --0 | --0 |
| Other non- operating income (expenses) | ---- | ---- | -100.92%-10K | ---- | ---6K | --1.09M | ---- | ---- | ---- | ---- |
| Income before tax | -599.89%-12.26M | 25.88%-8.95M | 30.14%-30M | -1.75M | -12.08M | -323.40%-42.94M | 108.47%19.22M | -320.76%-226.84M | -44.51%-53.91M | 20.54%-37.31M |
| Income tax | 0 | 0 | 25.91%-532K | 0 | 0 | -135.09%-718K | 153.20%2.05M | 53.25%-3.85M | -55.89%-8.23M | 35.27%-5.28M |
| Net income | -599.89%-12.26M | 25.88%-8.95M | 30.21%-29.47M | -1.75M | -12.08M | -345.83%-42.22M | 107.70%17.17M | -388.10%-223M | -42.64%-45.69M | 17.45%-32.03M |
| Net income continuous Operations | -599.89%-12.26M | 25.88%-8.95M | 30.21%-29.47M | ---1.75M | ---12.08M | -345.83%-42.22M | 107.70%17.17M | -388.10%-223M | -42.64%-45.69M | 17.45%-32.03M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -599.89%-12.26M | 25.88%-8.95M | 30.21%-29.47M | -1.75M | -12.08M | -345.83%-42.22M | 107.70%17.17M | -388.10%-223M | -42.64%-45.69M | 17.45%-32.03M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -599.89%-12.26M | 25.88%-8.95M | 30.21%-29.47M | -1.75M | -12.08M | -345.83%-42.22M | 107.70%17.17M | -388.10%-223M | -42.64%-45.69M | 17.45%-32.03M |
| Basic earnings per share | -617.77%-0.1 | 50.00%-0.05 | 42.86%-0.2 | -0.0139 | -0.1 | -359.33%-0.35 | 104.13%0.135 | -27.93%-3.2708 | -13.63%-2.5568 | 19.64%-2.25 |
| Diluted earnings per share | -617.77%-0.1 | 50.00%-0.05 | 42.86%-0.2 | -0.0139 | -0.1 | -3.73%-0.35 | 89.68%-0.3374 | -27.93%-3.2708 | -13.63%-2.5568 | 19.64%-2.25 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | GBP |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg